Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis

Archives of Ophthalmology

Volumn 116, Issue 11, 1998, Pages 1456-1461

  Dees, Chrisjan ^a   Arnold, Jennifer J ^a   Forrester, John V ^b   Dick, Andrew D ^b,c  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PREDNISOLONE ACETATE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; OCULAR HISTOPLASMOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; UVEITIS; VISUAL ACUITY;

EID: 0031772985     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.11.1456     Document Type: Article

References (26)

1. Forrester W, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990;9:75-84.
2. Dreyer RF, Oass JDM. Multifocal choroiditis and panuveitis. Arch Ophthalmol. 1984;102:1776-1784.
3. Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthatmol. 1988;72:646-659.
4. Kilmartin D, Forrester JV, Dick AD. Cyclosporin A-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia. Arch Ophthalmol. 1998;116:249-250.
5. Reddy VM, Zamora RL, Kaplan HJ. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995;120:291-301.
6. Woods AC, Wahlen HE. The probable role of benign histoplasmosis in the etiology of granulomatous uveitis. Am J Ophthalmol. 1960;49:205-220.
7. Saraux H, Lefrançois A, Offret H. La choroidopathie macutaire hemorragique du sujetjeune ou pseudo-histoplamose. J Fr Ophtalmol. 1979;2:349-354.
8. Flage T, Sand AB, Syrdalen P. Haemorrhagic maculopathy in young adults. Acta Ophthalmol. 1977:489-496.
9. Scheider A. Multifocal inner choroiditis. German J Ophthalmol. 1993;2:1-9.
10. Watzke RC, Claussen RW. The long-term course of multifocal choroiditis (presumed ocular histoplasmosis). Am J Ophthalmol. 1981;91:750-760.
11. Parvan PR, Margo CE. Submacular neovascular membrane and focal granulomatous inflammation. Ophthalmology. 1996;103:586-589.
12. Saxe SJ, Grossniklavas HE, Lopez PF, Lambert HM, Sternberg P Jr, L'Hernault N. Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome. Arch Ophthalmol. 1993;111:88-95.
13. Suttorp-Schulten MSA, Bollemeijer JG, Bos PJM, Rothova A. Presumed ocular histoplasmosis in the Netherlands: an area without histoplasmosis. Br J Ophthalmol. 1997;81:7-11.
14. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234-235.
15. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1987;105:1499-1507.
16. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983;96:275-282.
17. Nussenblatt RB, Gery I, Weiner HL, et al. A masked, randomized dose-response study between Cyclosporin A and G in the treatment of sight-threatening uveitis of noninfectious origin. Am J Ophthalmol. 1993;115:583-591.
18. Towler HMA, Whiting PH, Forrester W. Combination low dose Cyclosporin A and steroid therapy in intraocular inflammation. Eye. 1990;4:514-520.
19. Campochiaro PA, Morgan KM, Conway BP, Stathos J. Spontaneous involution of subfoveal neovascularization. Am J Ophthalmol. 1990;109:668-675.
20. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularisation: five-year results. Arch Ophthalmol. 1994;112:500-509.
21. Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome: visual prognosis. Ophthalmology. 1984;91:1592-1602.
22. Macular Photocoagulation Study Group. The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxtafoveal choroidal neovascularization. Arch Ophthalmol. 1995;113:190-194
23. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol. 1989;107:344-352.
24. Gass JD. Biomicroscopic and histopathologic considerations regarding the feasability of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118:285-298.
25. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis. Ophthalmology. 1997;104:22-26.
26. Melberg NS, Thomas MA, Dickinson JD, Valluri S. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology. 1996;103:1064-1067.